{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:00:18Z","timestamp":1777532418333,"version":"3.51.4"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T00:00:00Z","timestamp":1430697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125519","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T18:21:52Z","timestamp":1430763712000},"page":"e0125519","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"umin000006081","registry":"10.18810\/umin-japan"}],"author":[{"given":"Masahiro","family":"Takihata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinobu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Terauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/01.HYP.19.5.403","article-title":"Diabetes mellitus and hypertension","volume":"19","author":"M Epstein","year":"1992","journal-title":"Hypertension"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","year":"2003","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08037050701461084","article-title":"2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"16","year":"2007","journal-title":"Blood Press"},{"key":"ref5","first-page":"3","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)","volume":"32","year":"2009","journal-title":"Hypertens Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"S Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/HJH.0b013e3280bad9b4","article-title":"Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system","volume":"25","year":"2007","journal-title":"J Hypertens"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1007\/s00125-010-2040-1","article-title":"Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials","volume":"54","year":"2011","journal-title":"Diabetologia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"EJ Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000024416.33113.0A","article-title":"Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(96)10244-0","article-title":"Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"ref16","first-page":"870","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"45","year":"2001","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/dc06-1998","article-title":"Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes","volume":"30","year":"2007","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2337\/diacare.24.12.2091","article-title":"Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic\/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","article-title":"Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial","volume":"51","year":"2008","journal-title":"Hypertension"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1291\/hypres.26.201","article-title":"Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure","volume":"26","author":"K Kuramoto","year":"2003","journal-title":"Hypertens Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"RO Estacio","year":"1998","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1291\/hypres.27.181","article-title":"Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial","volume":"27","year":"2004","journal-title":"Hypertens Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","article-title":"Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"L Hansson","year":"1999","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1479164112447310","article-title":"The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA study","volume":"9","author":"H Daikuhara","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2840-10-79","article-title":"Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function\u2014a crossover trial (AGENT)","volume":"10","author":"K Fukao","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2008.102","article-title":"Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study","volume":"73","year":"2008","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","year":"2007","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","article-title":"Thiazide diuretics, potassium, and the development of diabetes: a quantitative review","volume":"48","author":"AJ Zillich","year":"2006","journal-title":"Hypertension"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00607430","article-title":"Pharmacokinetics of hydrochlorothiazide in man","volume":"12","author":"B Beermann","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0002-9343(96)00270-7","article-title":"Metabolic manifestations of low-dose diuretics","volume":"101","author":"JM Neutel","year":"1996","journal-title":"Am J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1291\/hypres.31.43","article-title":"Effects of manidipine\/delapril versus olmesartan\/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus","volume":"3","author":"R Fogari","year":"2008","journal-title":"Hypertens Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.jhh.1001726","article-title":"Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus","volume":"18","author":"A Mugellini","year":"2004","journal-title":"J Hum Hypertens"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/dc06-1373","article-title":"Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome","volume":"29","author":"STAR Investigators","year":"2006","journal-title":"Diabetes Care"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:46:57Z","timestamp":1540025217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125519"}},"subtitle":[],"editor":[{"given":"Yoshihiro","family":"Fukumoto","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,4]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125519","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,4]]}}}